Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 3
2007 1
2008 6
2009 2
2010 3
2011 5
2012 7
2013 14
2014 20
2015 7
2016 12
2017 11
2018 13
2019 18
2020 23
2021 13
2022 7
2023 11
2024 4
2025 4
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

161 results

Results by year

Filters applied: . Clear all
Page 1
The Microbiota as a Potential Cause of Disease.
Santangelo G, Lamorgese L, Tonti N, Porpora MG, Palaia I, Tomao F, Di Donato V, Fischetti M, Di Mascio D, Giancotti A, Perniola G, Muzii L. Santangelo G, et al. Among authors: tomao f. Diseases. 2026 Jul 20;14(7):260. doi: 10.3390/diseases14070260. Diseases. 2026. PMID: 42505588 Free PMC article. Review.
Antibody-drug conjugates: a practical review on clinical management of toxicities.
De Palma A, Marenco M, Mancini S, Palaia I, Barchiesi G, Di Donato V, Perniola G, Petrella MC, Muzii L, Tomao F. De Palma A, et al. Among authors: tomao f. Expert Rev Anticancer Ther. 2026 Jun 8:1-19. doi: 10.1080/14737140.2026.2685304. Online ahead of print. Expert Rev Anticancer Ther. 2026. PMID: 42234409 Review.
Rational adjustment of dose to reduce adverse reactions (RADAR) in patients with platinum-sensitive recurrent ovarian cancer: Results from the phase II NEWTON trial (ENGOT-ov49).
Colombo N, Parma G, Tasca G, Di Palma MP, Tognon G, Lissoni AA, Fossati R, Carlucci L, Zucchetti M, Matteo C, Ferrero A, Bologna A, Mantiero M, Wimberger P, Katsaros D, Tomao F, Galli F, Lapresa M, Guarneri V, Ficarelli S, Canova S, Derio S, Girardi F, Zizioli V, Katrini J, Massa D, Rulli E, Biagioli E; NEWTON study group. Colombo N, et al. Among authors: tomao f. Eur J Cancer. 2026 May 15;239:116685. doi: 10.1016/j.ejca.2026.116685. Epub 2026 Mar 27. Eur J Cancer. 2026. PMID: 41950571 Clinical Trial.
Clinical relevance and prognostic role of PDL-1 expression in cervical cancer patients.
Arnò A, Pernazza A, Leopizzi M, Benedettucci E, Cerbelli B, Manganaro L, Barchiesi G, Tomao F, Perniola G, Di Donato V, Gentile G, Mancini S, De Felice F, Muzii L, Rocca CD, Palaia I. Arnò A, et al. Among authors: tomao f. Arch Gynecol Obstet. 2026 May 9;313(1):193. doi: 10.1007/s00404-026-08454-8. Arch Gynecol Obstet. 2026. PMID: 42104993 No abstract available.
Outcomes of node-positive cervical cancer treated with neoadjuvant chemotherapy followed by radical surgery: a single-center approach to a challenging disease.
Palaia I, Perniola G, Tonti N, Tomao F, Pernazza A, Barchiesi G, Manganaro L, De Felice F, Musella A, Paoni Saccone G, Tanzi F, Mancini S, Vestri A, Alunni Fegatelli D, Benedetti Panici P, Muzii L, Di Donato V. Palaia I, et al. Among authors: tomao f. J Gynecol Oncol. 2026 Mar 30. doi: 10.3802/jgo.2026.37.e87. Online ahead of print. J Gynecol Oncol. 2026. PMID: 41958171 Free article.
Prolyl-isomerase Pin1 drives platinum resistance by regulating Notch3 stability and function in ovarian cancer.
Giuli MV, Mancusi A, Natiello B, Di Cristofano S, Reali R, Pignataro MG, D'Andrea D, Di Magno L, Nicoletti C, Giorgi A, Macone A, Camerini S, Casella M, Peruzzi G, Zema S, Canettieri G, Tomao F, Palaia I, Pernazza A, Rustighi A, Palermo R, Raimondo D, Monti A, Doti N, d'Amati G, Del Sal G, Screpanti I, Talora C, Bellavia D, Checquolo S. Giuli MV, et al. Among authors: tomao f. J Exp Clin Cancer Res. 2026 Feb 11;45(1):71. doi: 10.1186/s13046-026-03658-x. J Exp Clin Cancer Res. 2026. PMID: 41673759 Free PMC article.
Prognostic impact of microscopic residual disease after neoadjuvant chemotherapy in patients undergoing interval debulking surgery for advanced ovarian cancer.
Di Donato V, Caruso G, Golia D'Augè T, Perniola G, Palaia I, Tomao F, Muzii L, Pernazza A, Della Rocca C, Bogani G, Benedetti Panici P, Giannini A. Di Donato V, et al. Among authors: tomao f. Arch Gynecol Obstet. 2025 Feb;311(2):429-436. doi: 10.1007/s00404-024-07775-w. Epub 2024 Oct 13. Arch Gynecol Obstet. 2025. PMID: 39397086 Free PMC article.
161 results